Enhanced Fc-Dependent Cellular Cytotoxicity of Fc Fusion Proteins Derived from TNF Receptor II and LFA-3 by Fucose Removal from Asn-Linked Oligosaccharides
スポンサーリンク
概要
- 論文の詳細を見る
- Japanese Biochemical Societyの論文
- 2006-12-01
著者
-
WAKITANI Masako
Antibody Research Laboratories, Kyowa Hakko Kogyo Co., Ltd.
-
Shitara Kenya
協和醗酵工業東京研究所
-
Shitara Kenya
Department Of Antibody Research Pharmaceutical Research Center Kyowa Hakko Kogyo Co. Ltd.
-
Shitara Kenya
Tokyo Research Laboratories Kyowa Hakko Kogyo Co. Ltd.
-
Nakamura Kazuyasu
Biofrontier Laboratory Kyowa Hakko Kogyo Co. Ltd.
-
Wakitani Masako
Department Of Antibody Research Pharmaceutical Research Center Kyowa Hakko Kogyo Co. Ltd.
-
Wakitani Masako
Antibody Research Laboratories Kyowa Hakko Kogyo Co. Ltd.
-
SHOJI HOSAKA
Department of Antibody Research, Pharmaceutical Research Center, Kyowa Hakko Kogyo Co., Ltd.
-
KOBAYASHI Yukari
BioFrontier Laboratory, Kyowa Hakko Kogyo Co., Ltd.
-
UCHIDA Kazuhisa
Department of Antibody Research, Pharmaceutical Research Center, Kyowa Hakko Kogyo Co., Ltd.
-
NIWA Rinpei
Department of Antibody Research, Pharmaceutical Research Center, Kyowa Hakko Kogyo Co., Ltd.
-
Uchida Kazuhisa
Department Of Antibody Research Pharmaceutical Research Center Kyowa Hakko Kogyo Co. Ltd.
-
Niwa Rinpei
Department Of Antibody Research Pharmaceutical Research Center Kyowa Hakko Kogyo Co. Ltd.
-
Shoji Hosaka
Department Of Antibody Research Pharmaceutical Research Center Kyowa Hakko Kogyo Co. Ltd.
-
Niwa Rinpei
Antibody Research Laboratories Kyowa Hakko Kirin Co. Ltd
-
Kobayashi Yukari
Biofrontier Laboratory Kyowa Hakko Kogyo Co. Ltd.
-
Shitara Kenya
Department Of Strategic Product Planning Kyowa Hakko Kirin Co. Ltd
-
Shoji-Hosaka Emi
Department of Antibody Research, Pharmaceutical Research Center, Kyowa Hakko Kogyo Co., Ltd.
関連論文
- Mouse-Human Chimeric Anti-Tn IgG1 Induced Anti-tumor Activity against Jurkat Cells in Vitro and in Vivo(Pharmacology)
- 糖鎖に関わる応用研究の潮流と展開 : 抗体医薬
- Enhanced Fc-Dependent Cellular Cytotoxicity of Fc Fusion Proteins Derived from TNF Receptor II and LFA-3 by Fucose Removal from Asn-Linked Oligosaccharides
- Fucose Removal from Complex-Type Oligosaccharide Enhances the Antibody-Dependent Cellular Cytotoxicity of Single-Gene-Encoded Bispecific Antibody Comprising of Two Single-Chain Antibodies Linked to the Antibody Constant Region
- Engineered anti-CD20 antibodies with enhanced complement-activating capacity mediate potent anti-lymphoma activity
- Engineered therapeutic antibodies with improved effector functions